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Ticks  have  serious  impacts  on  animal  and human  health,  causing  signiﬁcant  economic  losses
in cattle  breeding.  Besides  damage  due  to  the  hematophagous  behavior,  they  transmit
several  pathogens.  Low  cost  and  environmental  safety  have  made  vaccines  a promising
alternative  control  method  against  tick  infestation.  Metalloproteases  (MPs)  have  been
shown  to be essential  for  diverse  biological  functions  in hematophagous  organisms,  inhibi-
ting blood  clotting,  degrading  extracellular  matrix  proteins,  and  inhibiting  host  tissue  repair
via  anti-angiogenic  activity.  In this  study,  we analyzed  the  immunoprotective  potential
of  a recombinant  MP against  Rhipicephalus  (Boophilus)  microplus  infestation.  First,  a cDNA
encoding  R. microplus  amino  acids  sequence  with  highly  conserved  regions  of  the  metzincin
(reprolysin)  group  of  MP  was  identiﬁed  (BrRm-MP4).  After  expression  and  puriﬁcation,
recombinant  BrRm-MP4  was used  as  a vaccinal  antigen  against  R.  microplus  infestation  in
cattle  (Bos  taurus  taurus).  All vaccinated  bovines  developed  immune  response  to the  antigen,
resulting  in increased  antibody  level  throughout  the immunization  protocol.  Immuniza-
tion  with  rBrRm-MP4  reduced  tick  feeding  success,  decreasing  the  number  of  engorged
females  and  their  reproduction  potential,  representing  a  60%  overall  protection.  These
results  show  that rBrRm-MP4  provides  protection  against  tick  infestation,  placing  it is a
potential  candidate  for an  anti-tick  vaccine.∗ Corresponding author at: Centro de Biotecnologia, Universidade
ederal do Rio Grande do Sul, Av. Bento Gonc¸ alves 9500, C.P. 15005, 91501-
70 Porto Alegre, RS, Brazil. Tel.: +55 51 33086082;
ax: +55 51 33087309.
E-mail address: trmgn@cbiot.ufrgs.br (C. Termignoni).
http://dx.doi.org/10.1016/j.vetpar.2014.11.007
304-4017/© 2014 Elsevier B.V. All rights reserved.© 2014  Elsevier  B.V.  All  rights  reserved.
1. Introduction
The cattle tick Rhipicephalus (Boophilus) microplus
affects cattle both directly and indirectly, by blood feed-
ing and as a vector of several pathogens. In veterinary
medicine, R. microplus is one of the most important ectopar-
asites worldwide, causing considerable economic losses
(Rechav, 1992; Grisi et al., 2014). Acaricides are the main
components of integrated tick control strategies, in spite of
arasitolo108 A. Ali et al. / Veterinary P
the drawbacks associated with the use of these chemicals,
like the selection of acaricide-resistant tick populations
and risks of contamination by drug residues in dairy and
meat products (Graf et al., 2004; de la Fuente and Kocan,
2006; Bissinger and Roe, 2010; Hajdusek et al., 2010). In
this scenario, anti-tick vaccines have emerged as an alter-
native tool to control tick infestation (de la Fuente et al.,
1999; Rodriguez-Mallon et al., 2012; de la Fuente et al.,
2007). The potential advantages of a vaccine-based con-
trol strategy are several, such as better cost-effectiveness,
lower environmental contamination hazard, improved
prevention of drug resistance, slender chances of pathogen
transmission, and prospective applicability in a wide
variety of hosts (de la Fuente et al., 1999; Graf et al.,
2004; de la Fuente et al., 2007; Rodriguez-Mallon et al.,
2012).
In order to develop anti-tick vaccines, the ﬁrst step is
the identiﬁcation of effcacious antigens (Willadsen, 2004).
With that in mind, various approaches have been devel-
oped to obtain an effective vaccine against R. microplus.
First attempts were done using complex tick extracts to
induce host immune response in cattle and then testing the
immunoprotective activity challenging the animals with
ticks (Willadsen, 2004; Sonenshine et al., 2006). The glyco-
protein Bm86, a tick gut epithelial cell protein (Rand et al.,
1989; Muhammad et al., 2008), became the ﬁrst tick anti-
gen used in a commercial vaccine (Canales et al., 1997;
Willadsen, 2004; de la Fuente et al., 2007). Since this anti-
gen does not confer enough protection against several R.
microplus populations (Garcia-Garcia et al., 2000; Cunha
et al., 2012), the search for new recombinant proteins for an
anti-tick vaccine gained a strong impetus (Willadsen, 2006;
Willadsen, 2004; Guerrero et al., 2012). Potential candi-
date antigens in the composition of a vaccine against R.
microplus include proteins with a role in several physiolog-
ical process regulations (Willadsen et al., 1996; Parizi et al.,
2012a; de la Fuente and Merino, 2013). Our research group
is also investigating the vaccine potential of a number of
tick proteins involved in different physiological roles, like
cell detoxiﬁcation and egg development (Leal et al., 2006;
Seixas et al., 2008; Parizi et al., 2011, 2012b). Although sev-
eral antigens have been tested for their anti-tick efﬁcacy (de
la Fuente et al., 1999; Guerrero et al., 2012), only a few have
yielded promising results (Patarroyo et al., 2002; Hajdusek
et al., 2010; Almazan et al., 2010; de la Fuente and Merino,
2013).
Metalloproteases (MPs) are multifunctional proteins
that participate in diverse biological functions in several
organisms, regulating complex physiologic and pathologic
processes (Kessenbrock et al., 2010). A considerable num-
ber of studies have been speciﬁcally conducted to identify
and characterize metzincin MPs. Metzincin MPs mem-
bers have been found to participate in tissue development,
maintenance, remodeling, and in unspeciﬁc protein degra-
dation of intake proteins (Gomis-Ruth, 2009; Rivera et al.,
2010). MPs  have been identiﬁed in various tick species,
and are considered crucial for maintenance of blood meal
related functions (Francischetti et al., 2003; Harnnoi et al.,
2007; Decrem et al., 2008a; Barnard et al., 2012). The
up-regulation of MPs  transcription in salivary glands has
been correlated with tick blood feeding (Francischetti et al.,gy 207 (2015) 107–114
2003; Harnnoi et al., 2007; Decrem et al., 2008a, 2008b;
Barnard et al., 2012; Adamson et al., 2013). In Ixodes scapu-
laris, MPs  are secreted in saliva, playing an essential role in
ﬁbrin and ﬁbrinogen breakdown (Francischetti et al., 2003).
Inhibition of MPs  expression in Ixodes ricinus by RNA inter-
ference (RNAi) prevents tick blood meal completion and
inhibits saliva ﬁbrinolytic activity (Decrem et al., 2008a,
2008b). Host vaccination with an I. ricinus recombinant
MP impairs blood meal completion, besides reducing tick
weight gain and oviposition rates (Decrem et al., 2008b). In
Haemaphysalis longicornis,  six MPs  were identiﬁed, one of
which was shown to be a potentially interesting immuno-
protective antigen (Harnnoi et al., 2007; Imamura et al.,
2009).
Despite the characterization of some tick MPs
(Francischetti et al., 2003; Harnnoi et al., 2007; Decrem
et al., 2008a, 2008b; Barnard et al., 2012; Adamson et al.,
2013), vaccination trials against R. microplus infestation
using these proteins as antigen remains to be evaluated.
It has been speculated that the cysteine-rich domain in
MPs  is a limiting factor in the recombinant production
of these proteins by prokaryotes (Ramos and Selistre-
De-Araujo, 2006), since a native-like conformation of
recombinant MPs  is supposed to be critical – as far as
retaining immunogenic properties is concerned. How-
ever, recently we  characterized several MP  putative
sequences in three tick species (Ali et al., 2014). Among
these, a R. microplus MP  (BrRm-MP4) was selected for
further investigation concerning its potential as a vaccinal
antigen, due to its ubiquitous transcriptional pattern
among R. microplus tissues and an amino acid sequence
putatively highly antigenic, as compared to other MPs
(Ali et al., 2014). Here, we show that vaccination of
bovines with rBrRm-MP4 reduces R. microplus infestation,
underlining the prospect that this recombinant antigen
is a potential candidate in the development of a feasible
vaccine.
2. Materials and methods
2.1. Ticks
All R. microplus ticks (Porto Alegre strain) were free
from Babesia spp. and Anaplasma spp., and sensitive to
all acaricides currently in the market. The colony has
been maintained experimentally by feeding on Hereford
calves (Bos taurus taurus)  since 1976. Calves were pur-
chased from a naturally tick-free area (Santa Vitória do
Palmar, RS, Brazil; 33◦32′2′′ S, 53◦20′59′′ W)  and main-
tained in an isolated stall at the Universidade Federal do
Rio Grande do Sul (UFRGS) – Brazil, to avoid infestation
by other ticks. Calves were handled following the insti-
tutional guidelines approved by local ethical committees
for animal use. Two weeks after the last inoculation, cattle
were challenged with 20,000 ten-day old larvae. From the
20th post-infestation day until the end of infestation, ticks
that detached spontaneously were collected and up to 5 g
of fully engorged female ticks (per day) were kept in Petri
dishes at 28 ◦C and 85% relative humidity for oviposition
and egg hatching.
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.2. Cloning
For RNA extraction, 15-day-old larvae were macerated
sing a mortar and a pestle in liquid nitrogen and total RNA
as extracted using TRIzol reagent (Invitrogen) accord-
ng to the manufacturer’s instructions. First-strand cDNA
as synthesized from ﬁve micrograms of total RNA sub-
itted to reverse transcription (RT) with SuperScript II
Invitrogen) according to the manufacturer’s instructions.
CR ampliﬁcation was performed using primers designed
or a sequence from R. microplus salivary glands metal-
oprotease (BrRm-MP4) deposited in GenBank (accession
umber: DQ118970). The forward (5′-TTTTTGCTA GCATG
TCAGTGTGATCATAGTACTCGTGCTG-3′) and reverse (5′-
AAAAGGATCCTTAGTGG TGGTGGTGGTGGTGTTTTTCTTC-
CACCTGTTGCCCG-3′) primers were designed in order to
ntroduce Nhe I and BamH I sites in the sequence for sub-
equent cloning into expression vector, in addition to a
is-tag DNA sequence downstream the BrRm-MP4 ORF. A
665-bp amplicon was generated in a 35-cycle PCR reac-
ion (94 ◦C for denaturation, 55 ◦C for annealing and 68 ◦C
or extension) using Elongase® Enzyme Mix  (Invitrogen).
he PCR fragment obtained was separated by electrophore-
is on 0.8% agarose gel and puriﬁed using the GeneClean
I Kit (Qbiogene). The amplicon was cloned in a pGEM-
 vector (Promega), transformed into Escherichia coli Top
0 strain and plated on Luria-Bertani (LB) agar plates
ontaining ampicillin (50 g/mL ampicillin). Correctness
f plasmid construction was conﬁrmed by PCR, hydrol-
sis with restriction enzymes and DNA sequencing. The
GEM-T/BrRm-MP4 was digested with Nhe I and BamH
 restriction enzymes, and the resulting fragment was
igated into the expression vector pET-5a. The plasmid pET-
a/BrRm-MP4 was puriﬁed and cloned product correctness
as conﬁrmed by PCR, digestion with restriction enzymes
nd DNA sequencing.
.3. BrRm-MP4 expression
Escherichia coli BL21 (DE3) RIL cells were transformed
ith pET-5a/BrRm-MP4 and plated on to LB agar plates
ontaining 100 g/mL ampicillin. A single colony contain-
ng the plasmid was used to inoculate 25 mL  LB broth
100 g/mL ampicillin) and grown overnight at 37 ◦C.
fter removal of medium by centrifugation at 5000 × g for
 min, the pellets were re-suspended in 500 mL  of fresh
B broth and incubated at 37 ◦C until OD600 reached 0.4.
rotein expression was induced with isopropyl -d-1-
hiogalactopyranoside (IPTG) at 1 mM ﬁnal concentration
nd bacteria were collected after 4 h of incubation.
.4. Puriﬁcation of recombinant BrRm-MP4
Induced cells from a 500 mL  culture were harvested
y centrifuging at 10,000 × g for 10 min  at 4 ◦C. The pel-
et was re-suspended in 20 mL  of PBS, pH 7.4, containing
 g/mL lysozyme (Invitrogen) and incubated for 1 h at
3 ◦C. Cells were harvested from the culture by centrifuga-
ion and subjected to three freeze/thaw cycles. Cell debris
ere removed by centrifugation (12,000 × g for 20 min),
nd the supernatant was collected. The pellet was  washedgy 207 (2015) 107–114 109
with equilibrium buffer (PBS, 30 mM imidazole, 500 mM
NaCl, pH 7.4), centrifuged at 10,000 × g for 10 min  and
the supernatant containing rBrRm-MP4 was collected. This
process was repeated twice for complete extraction of the
recombinant protein. The supernatant was ﬁltered through
a 0.45-m porosity ﬁlter (Millipore) and applied onto a
1 mL  HisTrap Ni+2 afﬁnity column (GE Healthcare), previ-
ously washed with distilled water and equilibrated with
equilibrium buffer. After sample application, unspeciﬁc
bound proteins were removed washing the column with
15 mL  of equilibrium buffer. The recombinant protein was
eluted using phosphate buffer (20 mM)  containing two
different imidazole concentrations (100 mM or 500 mM),
0.5 M NaCl, pH 7.4. The eluted samples were dialyzed
against PBS, pH 7.4 and protein concentrations were deter-
mined according to the Bradford method (Bradford, 1976).
To conﬁrm protein homogeneity, puriﬁcation steps
were monitored by 12% SDS-PAGE with 5% acrylamide
in stacking gel and 10% gradient in running gel. Protein
sample with buffer (5% SDS, 5% Tris pH 6.8, 0.2% bro-
mophenol blue and glycerol 50% in water) was run for
15 mA  in stacking gel and 20 mA in running gel at 4 ◦C. This
step was  followed by protein transfer using a polyvinyli-
dene diﬂuoride (PVDF) membrane at 70 V for 1 h at 4 ◦C
in 12 mM carbonate buffer pH 9.9. The membrane was
blocked with blocking buffer (5% skim milk in PBS) for 1 h at
room temperature and subsequently incubated with anti-
His tag bovine IgG conjugated with alkaline phosphatase
(Sigma–Aldrich). The membrane was  washed with PBS and
incubated with nitroblue tetrazolium (NBT, Fermentas) and
5-bromo, 4-chloro, 3-indolylphosphate (BCIP, Fermentas)
to visualize the reaction.
2.5. Vaccination trial
Seven calves (18 months old) were randomly divided
into two  groups of three (control) and four (immunized)
animals. The treated group was  vaccinated with doses com-
posed of 1 mL  of oil adjuvant (Montanide 888 – Seppic and
Marcol 52- Exxon Mobil Corporation) plus 1 mL  of PBS con-
taining 100 g of puriﬁed rBrRm-MP4 in the ﬁrst and in
the second doses, and 200 g in the third and in the fourth
doses. The control group was injected four times with 1 mL
of PBS emulsiﬁed with 1 mL  of the same adjuvant. Calves
were vaccinated subcutaneously at 15-day intervals. Ten
days after the fourth injection, approximately 20,000 10-
day-old tick larva (from 1 g R. microplus hatched eggs) were
placed on the dorsal region of each calf. From day 20 after
infestation until the end of adult tick feeding period, all
tick females that had dropped from the host were daily col-
lected, counted and weighed. Engorged adult female ticks
were kept in Petri dishes at 28 ◦C and 85% relative humid-
ity to oviposition and further egg hatching. Protection was
estimated comparing the number of fully engorged ticks,
egg laying capacity and egg fertility in vaccinated and non-
vaccinated calves (Vaz et al., 1998).2.6. Serological analysis
Blood samples were collected from the jugular vein
of pre-immunized and post-immunized cattle on the
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rBrRm-M
 mass mFig. 1. SDS-PAGE and Western blot analysis: (1) 12% SDS-PAGE of 5 g of 
of  5 g of rBrRm-MP4 probed by using anti-His tag antibodies. Molecular
immunizations or tick challenge days. Blood was also
collected at the end of tick infestation period. After clot-
ting, sera were separated from blood by centrifugation at
5000 × g for 10 min  at 4 ◦C and stored at −20 ◦C for further
analysis. Sera obtained from both immunized and control
animals were analyzed by Western blot and ELISA in order
to determine the presence of anti-rBrRm-MP4 antibodies.
For Western blot analysis, puriﬁed rBrRm-MP4 was
subjected to 12% SDS-PAGE and transferred to a (PVDF)
membrane and then blocked with blocking buffer for
1 h (described above). After blocking, membranes were
incubated overnight with different concentrations of calf
serum (1: 2000) pre-incubated with E. coli lysate (Ferreira
et al., 2002). The membranes were washed three times
with blocking buffer and then incubated with peroxidase-
conjugated anti-bovine IgG (Sigma–Aldrich) as secondary
antibody for 1 h in a 1:5000 blocking buffer dilution.
After incubation with the secondary antibody, membranes
were washed three times with PBS and incubated with
30 mL  PBS containing 15 mg  3-3′ diaminobenzidine (DAB)
(Sigma–Aldrich), 60 L of 30% H2O2 and 900 L of 1% cobalt
chloride (Sigma–Aldrich) to visualize positive signals.ELISA was used in order to determine antibody
levels after rBrRm-MP4-vaccination. Microplates were
coated with 100 ng/well of rBrRm-MP4 for 12 h at
4 ◦C with 50 mM carbonate–bicarbonate buffer pH 9.6.P4 puriﬁed after Ni2+ afﬁnity column chromatography. (2) Western blot
arker (MM).  Molecular mass standards are expressed as kDa.
The rBrRm-MP4 was probed with bovine sera of vacci-
nated and control groups, and further detected with rabbit
anti-bovine IgG peroxidase conjugate. Development was
performed with 100 mM phosphate–citrate buffer pH 5.0
containing H2O2 and o-phenylenediamine. The reaction
was  stopped by the addition of H2SO4 12.5% and the
absorbance was  measured at 490 nm. The serum was con-
sidered positive when the reaction of post-inoculation
samples showed an optical density (OD) difference higher
than the mean plus 2 standard deviation units from the OD
from pre-inoculation serum (control) (Vaz et al., 1998).
2.7. Statistical analysis
Vaccine efﬁcacy was  estimated based on the differ-
ence in number and weight of fully engorged ticks, egg
laying capacity and egg fertility between vaccinated and
non-vaccinated calves. The overall protections were calcu-
lated as previously described (Willadsen et al., 1996) by the
interrelationship of these parameters using the equation:
100 × [1 − (NFE × WE  × WL)], where NFE, WE  and WL  are
the number of fully engorged females, egg laying capac-
ity and egg fertility from vaccinated cattle/control cattle,
respectively. Signiﬁcant differences of vaccination trial and
ELISA were determined using the t-test.
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an ectoparasite is indeed a realistic possibility (Rand et al.,
1989; Rodriguez et al., 1994, 1995a, 1995b). Indeed, a
Bm86-based tick vaccine was  the ﬁrst ectoparasite vaccine
available in the market (Rodriguez et al., 1994). However,ig. 2. Western blot analysis of rBrRm-MP4 probed with immunized bov
calves  4–7). Lane 1, pre-immune sera; lane 2, pre-infestation sera; lane 3
. Results
.1. Expression and puriﬁcation of rBrRm-MP4
rBrRm-MP4 expressed in E. coli was mostly produced as
nclusion bodies and recovered in the insoluble fraction of
ell lysate. After solubilization and afﬁnity chromatography
teps, rBrRm-MP4 was obtained as a homogeneous protein
Fig. 1) with a ﬁnal yield of 500 g/L of growth medium. The
pparent size of the recombinant protein is in accordance
ith its in silico predicted molecular mass of 62 kDa (Fig. 1).
.2. Immunogenicity analysis
Immunogenic analysis of rBrRm-MP4 was performed
sing bovine sera from vaccinated and control groups.
estern blot show speciﬁc rBrRm-MP4 recognition by vac-
inate bovine sera (Fig. 2) while ELISA detected an increase
n rBrRm-MP4 antibody level of immunized group after
he third inoculation, and fourth booster resulted in a
urther rise in anti-rBrRm-MP4 antibodies (Fig. 3). High-
st antibody level against rBrRm-MP4 was observed in all
mmunized animals after the fourth immunization, and
emaining similar until the end of tick infestation.
.3. Vaccine efﬁcacy
The number of engorged female ticks, egg laying capac-
ty and egg fertility were used to estimate vaccination
ffectiveness. Table 1 shows these biological parameters
or vaccinated and non-vaccinated tick infested bovines.
accination with rBrRm-MP4 signiﬁcantly decreased tick
umber and egg hatching by 42.9% and 14.8%, respectively.
gg laying capacity was affected approximately by 17.5%.
he overall protection achieved with this antigen against
ick infestation was 60%.. Discussion
The cattle tick R. microplus is an obligate
ematophagous ectoparasite, and causes major problems. Sera from control group (calves 1–3) and rBrRm-MP4 vaccinated group
festation sera.
in cattle production. Worldwide, tick control relies pri-
marily on the use of chemical acaricides, although several
studies have focused on the potential of vaccines as an
alternative approach (Willadsen, 2004; Guerrero et al.,
2012; de la Fuente and Merino, 2013). There is ample
evidence showing that vaccination with deﬁned proteic
antigens is able to induce signiﬁcant immunity against
tick infestation (Willadsen, 2004). Tick resistance against
vaccine antigens is less likely than resistance against
chemical acaricides, because numerous different antibod-
ies are usually generated against multiple antigen epitopes
(Hajdusek et al., 2010). The demonstration that recombi-
nant forms of the protein Bm86 confer protection against
R. microplus infestations was a major achievement in par-
asite vaccinology, proving that a vaccine to protect againstFig. 3. Kinetics of the humoral response of bovines immunized with
rRmBr-MP4 were determined by indirect ELISA (sera diluted 1:1000). Sera
from control group (calves 1–3) and rBrRm-MP4 vaccinated group (calves
4–7). Arrows indicate the days of the immunizations, and the dot the day
of  tick infestation. *p < 0.05; **p < 0.01 (Student’s t-test).
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Table  1
Biological parameter of detached R. microplus from rBrRm-MP4 vaccinated and control cattle groups.
Groups Animals Fully engorgeda Index
Number Weight (g) Eggs laying capacityb Eggs fertilityc
rBrRm-MP4 1 1069 309 0.420 0.280
2  1801 537 0.323 0.274
3  908 267 0.439 0.324
4  2409 650 0.346 0.294
Total  6187 1762 1.53 1.172
Mean 1547 441 0.38 0.293
SD  694 183 0.06 0.022
Control 5  3061 811 0.396 0.355
6  2099 589 0.497 0.325
7  2965 858 0.453 0.386
Total  8125 2258 1.35 1.066
Mean  2708 753 0.45 0.355
SD  530 144 0.05 0.031
Differenced 42.89* 41.46* 14.80 17.53*
a Female ticks detached during infestation period.
b The eggs weight laid by sample of fully engorged tick during infestation period was  used to calculate the proportion of the weight of ticks that was
converted into eggs.
c
oup).
Eggs fertility (laid eggs converted into larvae).
d Difference (%) = 100 × (1 − mean value of vaccinated group/control gr
* Statistically signiﬁcant (p < 0.05).
trials conducted in Brazil showed that vaccines based on
this antigen alone were unable to control R. microplus
(Cunha et al., 2012). Notably, a vaccine produced with
Bm95, a Bm86-homologous protein, offered protection
against the Argentinian R. microplus strain A, which is
insensitive to Bm86-based vaccines (Garcia-Garcia et al.,
2000). Limitations associated with the Bm86 vaccines also
included limited efﬁcacy against non-Rhipicephalus tick
species, reinforcing the need to pursue new vaccines (de
la Fuente and Merino, 2013).
Prolonged tick attachment and subsequent blood feed-
ing on vertebrates host rely on many bioactive molecules
secreted by salivary glands. This cocktail of pharma-
cologically active molecules also facilitates pathogen
transmission, which lends support to their use as poten-
tial candidates for anti-tick vaccines that could limit tick
infestations and interfere with tick-borne pathogen trans-
mission (Merino et al., 2013a,b). For this reason, tick saliva
components have attracted attention, posing as prospec-
tive antigen vaccine candidates. Salivary MPs  have been
shown to participate in ﬁbrin and ﬁbrinogen degrada-
tion, contributing to saliva anti-blood clotting activity
(Francischetti et al., 2003). Also, it was proposed that I.
scapularis salivary MPs  inhibits microvascular endothe-
lial cell proliferation and degrades both  and  subunits
of integrins 51 and 11 (Francischetti et al., 2005;
Kazimirova and Stibraniova, 2013). Previous studies using
H. longicornis MP  as antigen demonstrated that nymph and
adult tick mortality increases (Imamura et al., 2009). In
I. ricinus,  inhibition of MPs  expression by RNAi prevents
completion of tick blood meal and impairs tick saliva ﬁbri-
nolytic and ﬁbrinogenolytic activities (Decrem et al., 2008a,
2008b). Furthermore, vaccination of hosts with a recom-
binant MP  reduces I. ricinus blood meal, weight gain and
oviposition rates (Decrem et al., 2008b). Other studies also
support the idea that MPs  could be useful as an antigen inan anti-tick vaccine (Decrem et al., 2008b; Imamura et al.,
2009).
Recently we  identiﬁed putative reprolysin MPs  in three
tick species (Ali et al., 2014). Among these, a R. microplus
MP (BrRm-MP4) was selected for further studies because
of its transcriptional proﬁle in tick tissues, and in silico pre-
diction of immunogenic epitopes, which suggested that it
could offer protection against tick infestation. Accordingly,
after inoculation with rBrRm-MP4, bovines present anti-
rBrRm-MP4 antibodies after the third inoculation, which
persisted until the end of the experiment. Similarly to
other vaccination trials (Almazan et al., 2012; Carreón et al.,
2012; Moreno-Cid et al., 2013), the presence of antibodies
against antigens was  positively correlated (R2 = 0.6) with
decrease of tick numbers. Indeed, immunization of bovines
using rBrRm-MP4 reduced tick number, oviposition and
egg hatching, providing an overall protection of 60%, and
conﬁrming it as an immunoprotective antigen. Until now,
only a few antigens have produced this degree of protec-
tion against R. microplus infestation (Patarroyo et al., 2002;
Willadsen, 2004; Hajdusek et al., 2010; Almazan et al.,
2010; de la Fuente and Merino, 2013; Merino et al., 2013a,
2013b).
5. Conclusion
In conclusion, rBrRm-MP4 has potential as an antigen
in an anti-tick vaccine. rBrRm-MP4 vaccine efﬁcacy may
be improved by multi-antigenic formulations as well as
chimeric constructs using selected regions from BrRm-
MP4, together with other proteins that confer some degree
of immunity against ticks.Acknowledgments
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